KKR will invest $65M in China Cord Blood (CO +22.2%), the country’s largest operator of services...

|About: KKR (KKR)|By:, SA News Editor
KKR will invest $65M in China Cord Blood (CO +22.2%), the country’s largest operator of services for umbilical cord blood that is rich in stem cells, to capitalize on China’s fast growing healthcare services industry. As share prices of U.S.-listed Chinese companies take a beating, some PE firms sniff opportunities.